Efficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice

Published:2018-02-22 Issue:5 Volume:14 Page:1294-1304
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zhao Jun¹,Lu Jing²,Zhou Lurong³,Zhao Jimin²,Dong Ziming²

Affiliation:

1. Medical Oncology, Changzhi people's Hospital Affiliated to Shanxi Medical University, Changzhi, Shanxi Province, China

2. Department of Pathophysiology, Medical School of Zhengzhou University, Zhengzhou, Henan Province, China

3. Quality Control Department, Changzhi people's Hospital Affiliated to Shanxi Medical University, Changzhi, Shanxi Province, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1427532

Reference31 articles.

1. Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

2. Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients With Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301

3. Erlotinib in advanced non-small-cell lung cancer after gefitinib failure

4. Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment

5. Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis;Human Vaccines & Immunotherapeutics;2020-05-27

2. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma;Cells;2019-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3